DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20194893

Clinical significance of HPV-HC2 in diagnosis and prognosis of cervical lesions: a retrospective study

Soule Hassanati, Qin Fang, Yuanyuan Fang, Yan Xing

Abstract


Background: To evaluate the human papillomavirus HC2 different range detection values and their clinical significance in prediction of CIN lesions grades as well as their role in the follow-up outcome after treatment.

Methods: Using the hybrid capture 2 to detect and measure the HPV and the viral load quantity, we enrolled a total of 527 HPV positive women. All patients underwent thin prep liquid-based cytology test (TCT) and only 325 underwent colposcopy guided biopsy due to abnormal cytology results. All cytology and biopsy results were collected and analyzed according to the HPV viral load. Among these patients 108 patients were followed during 2years post-operatives and their prognosis results were collected and analyzed.

Results: The proportion and severity of cytological abnormalities was positively correlated with the HPV-HC2 viral load (P<0.05). There was a positive correlation between cervical biopsy results and the HPV viral load P <0.05). The more the HPV-HC2 viral load was, the higher CIN2-3 grade percentage was getting. However no statically significant correlation was found between the HPV-HC2 viral load and the follow up outcomes after treatment (P>0.05).

Conclusions: High HPV-HC2 viral load is significantly associated with the severity of cervical lesions (CIN), however it does not predict any further prognosis on follow-up after treatment.


Keywords


Cervical intraepithelial neoplasia, Follow-up, Human papillomavirus, Hybrid capture 2, Viral load

Full Text:

PDF

References


Peng J, Yuan Y, Shen F, Wang Y, Chen L, Liao DJ, et al. Cervical cancers manifest a high rate of infection by a high-risk human papilloma virus subtype but a very low rate of infection by a low-risk subtype in the Guiyang District of China. J Cancer. 2017;8(7):1263-70.

Shen G, Cheng J, Wang Y, Zhou P, Zhang G. Viral DNA load of high-risk human papilloma virus is closely associated with the grade of cervical lesions. Int J Clin Exp Med. 2014;7(12):5826-31.

de Sanjosé S, Brotons M, Pavón MA. The natural history of human papilloma virus infection. Best Pract Res Clin Obstet Gynaecol. 2018;47:2-13.

Tsai HT, Wu CH, Lai HL, Li RN, Tung YC, Chuang HY, et al. Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2544-9.

Xu Y, Dotto J, Hui Y, Lawton K, Schofield K, Hui P. High grade cervical intraepithelial neoplasia and viral load of high-risk human papillomavirus: significant correlations in patients of 22 years old or younger. Int J Clin Exp Pathol. 2009;2(2):169-75.

Huang MZ, Li HB, Nie XM, Jiang XM, Ming H, Li DQ, et al. Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions. Trans R Soc Trop Med Hyg. 2009;103(8):779-84.

Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet. 2002;360(9328):228-9.

Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, et al. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. J Low Genit Tract Dis. 2017;21(4):261-7.

Basu P, Muwonge R, Mittal S, Banerjee D, Ghosh I, Panda C, et al. Implications of semi-quantitative HPV viral load estimation by Hybrid capture 2 in colposcopy practice. J Med Screen. 2016;23(2):104-10.

Flores R, Papenfuss M, Klimecki WT, Giuliano AR. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer. 2006;118(5):1187-93.

Bottari F, Igidbashian S, Boveri S, Tricca A, Gulmini C, Sesia M, et al. HPV self-sampling in CIN2+ detection: sensitivity and specificity of different RLU cut-off of HC2 in specimens from 786 women. J Clin Pathol. 2017;70(4):327-30.

Origoni M, Carminati G, Rolla S, Clementi M, Sideri M, Sandri MT, et al. Human papillomavirus viral load expressed as relative light units (RLU) correlates with the presence and grade of preneoplastic lesions of the uterinecervix in atypical squamous cells of undetermined significance (ASCUS) cytology. Eur J Clin Microbiol Infect Dis. 2012;31(9):2401-6.

Jarboe EA, Venkat P, Hirsch MS, Cibas ES, Crum CP, Garner EI. A weakly positive human papillomavirus Hybrid Capture II result correlates with a significantly lower risk of cervical intraepithelial neoplasia 2,3 after atypical squamous cells of undetermined significance cytology. J Low Genit Tract Dis. 2010;14(3):174-8.

Wang W, Zhang XH, Li M, Hao CH, Zhao ZM, Liang HP. Association between viral loads of different oncogenic human papillomavirus types and the degree of cervical lesions in the progression of cervical Cancer. Clin Chim Acta. 2018;483:249-55.

Liu M, Yan X, Zhang M, Li X, Li S, Jing M. Influence of human papillomavirus infection on the natural history of cervical intraepithelial neoplasia 1: a meta-analysis. Biomed Res Int. 2017;2017:8971059.

Dalstein V, Riethmuller D, Prétet JL, Le Bail Carval K, Sautière JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer. 2003;106(3):396-403.

Salazar KL, Zhou HS, Xu J, Peterson LE, Schwartz MR, Mody DR, et al. Multiple human papilloma virus infections and their impact on the development of high-risk cervical lesions. Acta Cytol. 2015;59(5):391-8.

Jeong NH, Lee NW, Kim HJ, Kim T, Lee KW. High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia. J Obstet Gynaecol Res. 2009;35(4):706-11.

Byun JM, Jeong DH, Kim YN, Jung EJ, Lee KB, Sung MS, et al. Persistent HPV-16infection leads to recurrence of high-grade cervical intraepithelial neoplasia. Med (Baltimore). 2018;97(51):e13606.

Ryu A, Nam K, Kwak J, Kim J, Jeon S. Early human papillomavirus testing predicts residual/recurrent disease after LEEP. J Gynecol Oncol. 2012;23(4):217-25.

Niu XY, Feng YK. Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization. Sichuan Da Xue Xue Bao Yi Xue Ban. 2015;46(2):321-5.